On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queensland Trade Commissioner to Japan), and Ms. Annu Tamura (Senior Business Development Manager) to Hirotsu Bioscience headquarters in Tokyo.
During their visit, details of the progress that has been made on cancer-specific screening and the N-NOSE project in Japan were shared including progress on the large-scale clinical study for N-NOSE that is currently underway by QUT in Australia.
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .
2023.03.20HIROTSU BIO SCIENCE releases a cancer screening for “Pet Dogs”. “N-NOSE Dogs” Website now available. -Pre-order available, special discounts ar . . .
2023.03.10Our CEO made a courtesy call on Minister Yasutoshi Nishimura.
2023.02.27